AML-325 Prognostic Impact of RAS and C-KIT Mutations (Single vs. Multiple) in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) Treated With a Fludarabine, Cytarabine, and G-CSF (FLAG)– Based Regimen

Tareq Abuasab, Jatastu Senapati, Tapan Kadia, Farhad Ravandi, Courtney DiNardo, Naveen Pemmaraju, Maro Ohanion, Yesid Alvarado, Hagop Kantarjian, Gautam Borthakur

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'AML-325 Prognostic Impact of RAS and C-KIT Mutations (Single vs. Multiple) in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) Treated With a Fludarabine, Cytarabine, and G-CSF (FLAG)– Based Regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences